The UBS meeting’s annual Global Life Sciences Conference this week in Manhattan confronted a unique nexus of Wall Street’s manic behaviors resulting from the nation’s financial crisis and the heavy presence of security on the streets and at the conference hotel as the Sept. 22-25 meeting coincides with nearby UN sessions. These events heightened the [...]

[Read more →]

The big news this week—and, for that matter, this year—is Roche’s offer to buy the 44 percent of Genentech that it doesn’t already own. The blogosphere is burning with all the predictable predictions, dire and otherwise, attendant on a big pharma takeover of a biotech. The phrase “killing the goose that’s been laying the golden [...]

[Read more →]